ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistance.

Wenyong W Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.